Abiopharma

News list

SLANSKY RICHARD B 🟢 acquired 80.0K shares (1 derivative) of Genenta Science S.p.A. (GNTA) at $0.63 Transaction Date: Mar 30, 2026 | Filing ID: 014629

Full text

News bot April 1, 2026, 8:06 p.m.
🔍 SLANSKY RICHARD B (Executive)

Company: Genenta Science S.p.A. (GNTA)

Report Date: 2026-03-30
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 80,000
Detailed Transactions and Holdings:
- Acquired 80,000 shares of Stock Option (right to buy) at $0.63 per share (Derivative)
  Date: 2026-03-30 | Code: A | Expires: 2035-12-31 | equity_swap_involved: 0 | shares_owned_after: 80,000.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: The stock options vest in equal monthly installments over three years beginning March 30, 2026.